Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Thursday broker round-up UPDATE

Date: Thursday 06 Mar 2014

LONDON (ShareCast) - Advanced Medical Solutions: Investec ups target price from 97p to 121p and keeps a buy recommendation.

African Barrick Gold: Investec increases target price from 132p to 206p, but still recommends selling.

Arcontech: Northland shifts target price from 0.20p to 0.24p and keeps a buy recommendation.

Ashmore Group: JP Morgan cuts target price from 358p to 344p and retains its neutral rating.

AstraZeneca: UBS increases target price from 4150p to 4600p and maintains a buy recommendation.

Aviva: Panmure Gordon takes target price from 440p to 540p and upgrades from hold to buy.

Avon Rubber: N+1 Singer raises target price from 682p to 720p and maintains its buy recommendation.

BBA Aviation: JP Morgan ups target price from 356p to 378p and reiterates an overweight rating.

Betfair: Numis downgrades from buy to add with a target price of 1300p.

BHP Billiton: Canaccord Genuity ups target price from 2040p to 2100p and leaves its hold recommendation unchanged.

Booker Group: JP Morgan takes target price from 160p to 195p keeping an overweight rating.

British Sky Broadcasting Group: Westhouse Securities downgrades from buy to neutral with a target price of 985p.

Cineworld: Numis cuts target price from 400p to 380p, while upgrading from add to buy.

Close Brothers Group: Canaccord Genuity downgrades from buy to hold with a target price of 1500p.

Communisis: Panmure Gordon lowers target price from 84p to 83p keeping a buy recommendation.

Crawshaw Group: WH Ireland shifts target price from 25p to 32p and maintains a buy recommendation.

Croda International: N+1 Singer moves target price from 2700p to 2750p retaining a buy recommendation.

Devro: JP Morgan reduces target price from 357p to 297p and downgrades to neutral. Numis cuts target price from 330p to 285p, while upgrading from hold to add.

Faroe Petroleum: Panmure Gordon shifts target price from 184p to 190p and retains a buy recommendation.

Foxtons: Canaccord Genuity downgrades from buy to hold with a target price of 320p.

Fresnillo: Numis downgrades from buy to hold with a target price of 1000p.

Grafton Group: Jefferies ups target price from 450p to 480p, while leaving its underperform rating unchanged. Citi raises target price from 550p to 625p, but still recommends selling.

Hellermann Tyton: Goldman Sachs takes target price from 370p to 390p and retains a buy recommendation.

HSBC: Goldman Sachs cuts price target to 740p from 900p and removes from pan-European 'Conviction Buy' list, buy recommendation retained.

Imagination Technologies: FinnCap reduces target price from 230p to 165p, while keeping its hold recommendation.

Informa: Westhouse Securities cuts target price from 580p to 550p, while upgrading from neutral to add.

International Consolidated Airlines Group: UBS ups target price from 475p to 495p and keeps a buy recommendation.

Kazakhmys: Canaccord Genuity raises target price from 250p to 340p and retains its hold recommendation.

Lonmin: Westhouse Securities lowers target price from 300p to 280p and keeps a neutral rating.

LSL: Jefferies moves target price from 610p to 650p and reiterates a buy recommendation. Numis raises target price to 520p keeping an add rating.

Melrose: UBS lowers target price from 310p to 300p and keeps a neutral rating.

Moneysupermarket: Investec shifts target price from 218p to 222p and maintains its buy recommendation.

Polyus Gold International: JP Morgan cuts target price from 230p to 190p, while reiterating its neutral rating.

Premier Foods: Panmure Gordon takes target price from 130p to 166p and upgrades from sell to buy.

Regenersis: Panmure Gordon Panmure Gordon raises target price from 394p to 423p and maintains its buy recommendation.

Regus: Credit Suisse moves target price from 225p to 250p and keeps its outperform rating.

Rentokil Initial: Cantor Fitzgerald ups target price from 140p to 160p and stays with its buy recommendation.

Schroders: Canaccord Genuity raises target price from 2500p to 2800p and keeps its hold recommendation.

Shire Pharmaceuticals: UBS increases target price from 3180p to 3450p, while leaving its neutral rating unaltered.

SQS Software Quality Systems: Westhouse Securities raises target price from 560p to 620p, but downgrades from buy to add.

STV Group: Numis raises target price from 436p to 480p and maintains a buy recommendation.

Synthomer: N+1 Singer ups target price from 245p to 280p and retains its hold recommendation.

Tullett Prebon: Espirito Santo lowers target price from 354p to 337p and downgrades to neutral.

Wm Morrison: Jefferies cuts target price from 310p to 275p, while staying with its buy recommendation.

4 imprint: FinnCap raises target price from 752p to 780p and keeps a buy recommendation.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00
52 Week Low 177.20
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page